EFFICACY AND SAFTEY OF ESLICARBAZEPINE ACETATE AS FIRST ADD-ON TO LEVETIRACETAM OR LAMOTRIGINE MONOTHERAPY OR AS LATER ADJUNCTIVE TREATMENT FOR PATIENTS WITH UNCONTROLLED PARTIAL-ONSET SEIZURES: A MULTICENTER, OPEN-LABEL, NON-RANDOMIZED PHASE IV TRIAL